Caliper Reports $36M in Preliminary Q4 Revenues | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) - Caliper Life Sciences today reported preliminary fourth-quarter revenue of approximately $36 million and preliminary full-year revenue of $123.5 million.

The preliminary results reflect a 4 percent dip from $37.7 million in the fourth quarter of 2009 and a 5 percent decrease in annual revenues compared to 2009. The company said that organic revenues grew 10 percent year-over-year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."